Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Melanoma × TP protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Esophageal Squamous Cell Carcinoma 9 Esophageal Neoplasms 4 Uterine Cervical Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Cancer 1 Recurrence 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Melanoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Nivolumab 122 Ipilimumab 113 pembrolizumab 105 Cyclophosphamide 67 Interleukin-2 57 aldesleukin 53 Temozolomide 35 trametinib 34 Radiosurgery 34 Vemurafenib 32 Biopsy 31 dabrafenib 30 fludarabine 29 Radiotherapy 27 Blood Specimen Collection 27 sargramostim 26 fludarabine phosphate 25 Bevacizumab 25 Introns 21 Magnetic Resonance Spectroscopy 20 Dacarbazine 20 Specimen Handling 17 cobimetinib 16 Paclitaxel 16 Granulocyte-Macrophage Colony-Stimulating Factor 16 Cisplatin 16 encorafenib 15 binimetinib 15 incomplete Freund's adjuvant 14 Radiation 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡